CONSTRUCTION AND EXPRESSION OF VIRUS-LIKE PARTICLES AS INTERNAL CONTROL RNA FOR SARS-CoV DETECTION

Zhenyong LI,Jianzhou JING,Mingxia LIU,Lingbo QU,Zhitao LI,Yunlong WANG,Yufen ZHAO
DOI: https://doi.org/10.3321/j.issn:1001-5493.2006.01.010
2006-01-01
Abstract:For the detection of SARS–CoV using nucleic-acid based methods, the lack of uniform, safe, stable, and specific internal controls for monitoring the entire process from sample preparation, reverse transcription, to PCR amplification has been a problem influencing the specificity and sensitivity of many home-brew and commercially available such systems. The virus-like particles we produced are comparable in quality to those reported for other viruses, and proved a superior internal control for the detection of SARS-CoV using clinical specimens. A 1.7kb DNA fragment coding for the assembly protein and coat protein of MS2 phage, and a 270bp of SARS-CoV fragment with mutated sequences for the internal control probe were cloned and expressed using prokaryotic system. The particles were subject to real time RT-PCR with clinical SARS specimens. Virus-like particles were stable in human plasma and SM buffer for at least 30 days. RNase protection test indicated that various dilutions of virus-like particles could withstand RNase attack. Tests with clinical SARS specimens showed that the produced virus-like particles could be spiked in test samples to serve as the internal control for monitoring the complete detection process from sample preparation, reverse transcription, to PCR amplification. No cross reactions between the virus-like particles and SARS-CoV samples were found when the specific internal control robe was used. The SARS CoV RNA internal control virus-like particle is a useful, durable, ribonuclease-resistant viral RNA internal control for truly clinical assay.
What problem does this paper attempt to address?